Prognostic significance of serum IgE levels in primary breast cancer

Dennis Randall Ownby, Helen E. Ownby, Larry D. Roi, Laura M. Howard, Gloria H. Heppner, Michael J. Brennan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Serum IgE was measured in presurgical sera from 166 nonallergic women admitted to a comprehensive, multidisciplinary study of primary, operable breast cancer. During the follow-up period, which averaged 48 months, there were 71 recurrences. Patients were divided into two groups: those with IgE levels greater than the geometric mean value of 24 I.U. and those with levels less than the mean. The rate of tumor recurrence was significantly greater for the IgE > 24 group (p<0.03). IgE remained a significant prognostic indicator when evaluated by Cox regression analysis in conjunction with other known prognostic factors including: number of positive lymph nodes, clinical stage, menopausal status, estrogen receptor status, mitotic grade, tumor diameter, breast feeding history, and age of patient (p<0.015). IgE was not correlated with any of these known prognostic factors in individual analyses. We conclude that serum IgE level is a significant, independent prognostic indicator in primary breast cancer.

Original languageEnglish (US)
Pages (from-to)221-226
Number of pages6
JournalBreast Cancer Research and Treatment
Volume2
Issue number3
DOIs
StatePublished - Sep 1 1982
Externally publishedYes

Fingerprint

Immunoglobulin E
Breast Neoplasms
Serum
Recurrence
Breast Feeding
Estrogen Receptors
Neoplasms
Lymph Nodes
Regression Analysis

Keywords

  • IgE
  • breast cancer
  • prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ownby, D. R., Ownby, H. E., Roi, L. D., Howard, L. M., Heppner, G. H., & Brennan, M. J. (1982). Prognostic significance of serum IgE levels in primary breast cancer. Breast Cancer Research and Treatment, 2(3), 221-226. https://doi.org/10.1007/BF01806934

Prognostic significance of serum IgE levels in primary breast cancer. / Ownby, Dennis Randall; Ownby, Helen E.; Roi, Larry D.; Howard, Laura M.; Heppner, Gloria H.; Brennan, Michael J.

In: Breast Cancer Research and Treatment, Vol. 2, No. 3, 01.09.1982, p. 221-226.

Research output: Contribution to journalArticle

Ownby, DR, Ownby, HE, Roi, LD, Howard, LM, Heppner, GH & Brennan, MJ 1982, 'Prognostic significance of serum IgE levels in primary breast cancer', Breast Cancer Research and Treatment, vol. 2, no. 3, pp. 221-226. https://doi.org/10.1007/BF01806934
Ownby, Dennis Randall ; Ownby, Helen E. ; Roi, Larry D. ; Howard, Laura M. ; Heppner, Gloria H. ; Brennan, Michael J. / Prognostic significance of serum IgE levels in primary breast cancer. In: Breast Cancer Research and Treatment. 1982 ; Vol. 2, No. 3. pp. 221-226.
@article{ea6fddbe6ae84d81a9b682c8144ed36c,
title = "Prognostic significance of serum IgE levels in primary breast cancer",
abstract = "Serum IgE was measured in presurgical sera from 166 nonallergic women admitted to a comprehensive, multidisciplinary study of primary, operable breast cancer. During the follow-up period, which averaged 48 months, there were 71 recurrences. Patients were divided into two groups: those with IgE levels greater than the geometric mean value of 24 I.U. and those with levels less than the mean. The rate of tumor recurrence was significantly greater for the IgE > 24 group (p<0.03). IgE remained a significant prognostic indicator when evaluated by Cox regression analysis in conjunction with other known prognostic factors including: number of positive lymph nodes, clinical stage, menopausal status, estrogen receptor status, mitotic grade, tumor diameter, breast feeding history, and age of patient (p<0.015). IgE was not correlated with any of these known prognostic factors in individual analyses. We conclude that serum IgE level is a significant, independent prognostic indicator in primary breast cancer.",
keywords = "IgE, breast cancer, prognosis",
author = "Ownby, {Dennis Randall} and Ownby, {Helen E.} and Roi, {Larry D.} and Howard, {Laura M.} and Heppner, {Gloria H.} and Brennan, {Michael J.}",
year = "1982",
month = "9",
day = "1",
doi = "10.1007/BF01806934",
language = "English (US)",
volume = "2",
pages = "221--226",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of serum IgE levels in primary breast cancer

AU - Ownby, Dennis Randall

AU - Ownby, Helen E.

AU - Roi, Larry D.

AU - Howard, Laura M.

AU - Heppner, Gloria H.

AU - Brennan, Michael J.

PY - 1982/9/1

Y1 - 1982/9/1

N2 - Serum IgE was measured in presurgical sera from 166 nonallergic women admitted to a comprehensive, multidisciplinary study of primary, operable breast cancer. During the follow-up period, which averaged 48 months, there were 71 recurrences. Patients were divided into two groups: those with IgE levels greater than the geometric mean value of 24 I.U. and those with levels less than the mean. The rate of tumor recurrence was significantly greater for the IgE > 24 group (p<0.03). IgE remained a significant prognostic indicator when evaluated by Cox regression analysis in conjunction with other known prognostic factors including: number of positive lymph nodes, clinical stage, menopausal status, estrogen receptor status, mitotic grade, tumor diameter, breast feeding history, and age of patient (p<0.015). IgE was not correlated with any of these known prognostic factors in individual analyses. We conclude that serum IgE level is a significant, independent prognostic indicator in primary breast cancer.

AB - Serum IgE was measured in presurgical sera from 166 nonallergic women admitted to a comprehensive, multidisciplinary study of primary, operable breast cancer. During the follow-up period, which averaged 48 months, there were 71 recurrences. Patients were divided into two groups: those with IgE levels greater than the geometric mean value of 24 I.U. and those with levels less than the mean. The rate of tumor recurrence was significantly greater for the IgE > 24 group (p<0.03). IgE remained a significant prognostic indicator when evaluated by Cox regression analysis in conjunction with other known prognostic factors including: number of positive lymph nodes, clinical stage, menopausal status, estrogen receptor status, mitotic grade, tumor diameter, breast feeding history, and age of patient (p<0.015). IgE was not correlated with any of these known prognostic factors in individual analyses. We conclude that serum IgE level is a significant, independent prognostic indicator in primary breast cancer.

KW - IgE

KW - breast cancer

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=0020386219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020386219&partnerID=8YFLogxK

U2 - 10.1007/BF01806934

DO - 10.1007/BF01806934

M3 - Article

VL - 2

SP - 221

EP - 226

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -